Quality control of protein crystal suspensions using microflow imaging and flow cytometry

Area of Science:

• Pharmaceutical Science
• Biotechnology
• Analytical Chemistry

Background:

• Protein crystallization is crucial for processing and formulation, but sensitive to conditions, potentially yielding amorphous aggregates.
• Existing analytical methods for differentiating crystalline and amorphous protein states are limited, often requiring complex instrumentation and analysis.
• Developing accessible analytical techniques is essential for ensuring protein product quality.

Purpose of the Study:

• To evaluate the efficacy of light obscuration (LO), microflow imaging (MFI), and flow cytometry (FC) in differentiating amorphous and crystalline insulin.
• To identify robust methods for quality control in protein crystallization processes.

Main Methods:

• Investigated insulin in amorphous and crystalline states using LO, MFI, and FC.
• LO was used for qualitative particle size discrimination.
• MFI utilized mean light intensity for quantitative analysis, overcoming size distribution overlap.
• FC was employed to analyze light scattering differences for amorphous protein quantification.

Main Results:

• LO provided qualitative differentiation based on particle size.
• MFI, with mean light intensity analysis, enabled quantitative differentiation of amorphous and crystalline insulin.
• FC demonstrated potential for new quantitative analysis of amorphous protein via light scattering.

Conclusions:

• MFI and FC are promising techniques for rapid, high-throughput screening of protein crystallization conditions.
• These methods offer valuable tools for assessing and ensuring protein product quality by distinguishing amorphous from crystalline states.